GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procter & Gamble Health Ltd (NSE:PGHL) » Definitions » Debt-to-Asset

Procter & Gamble Health (NSE:PGHL) Debt-to-Asset : 0.00 (As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Procter & Gamble Health Debt-to-Asset?

Procter & Gamble Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹0 Mil. Procter & Gamble Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹0 Mil. Procter & Gamble Health's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ₹0 Mil.


Procter & Gamble Health Debt-to-Asset Historical Data

The historical data trend for Procter & Gamble Health's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procter & Gamble Health Debt-to-Asset Chart

Procter & Gamble Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Jun21 Jun22 Jun23 Jun24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.01 - 0.01 0.01

Procter & Gamble Health Quarterly Data
Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 - 0.01 -

Competitive Comparison of Procter & Gamble Health's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Procter & Gamble Health's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Procter & Gamble Health's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procter & Gamble Health's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Procter & Gamble Health's Debt-to-Asset falls into.



Procter & Gamble Health Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Procter & Gamble Health's Debt-to-Asset for the fiscal year that ended in Jun. 2024 is calculated as

Procter & Gamble Health's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Procter & Gamble Health  (NSE:PGHL) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Procter & Gamble Health Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Procter & Gamble Health's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Procter & Gamble Health Business Description

Traded in Other Exchanges
Address
Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.

Procter & Gamble Health Headlines